Amedisys (AMED) Tops Q2 EPS by 22c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $91.05 -0.12%
EPS Growth %: +2.0%
Financial Fact:
Total other expense, net: 3.84M
Today's EPS Names:
NLY, CP, RUSHA, More
EPS Growth %: +2.0%
Financial Fact:
Total other expense, net: 3.84M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.00, $0.22 better than the analyst estimate of $0.78. Revenue for the quarter came in at $411.6 million versus the consensus estimate of $403.62 million.
GUIDANCE:
Amedisys sees FY2018 EPS of $3.32-$3.41, versus the consensus of $3.10. Amedisys sees FY2018 revenue of $1.63-1.65 million, versus the consensus of $1.63 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- VIST Financial Corp. (VIST) Misses Q1 EPS by 19c
- ChampionX (CHX) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
